Spravato vs Generic Ketamine: Which Is Right for You?

Q: What is the difference between Spravato and ketamine?

Spravato contains esketamine, which is the S-enantiomer (mirror-image molecule) of ketamine. Racemic ketamine, the generic form, contains both the S- and R-enantiomers. Spravato is an FDA-approved intranasal spray that must be administered at certified healthcare facilities. Generic ketamine can be prescribed off-label in various forms including oral, sublingual, IV, and intramuscular, and oral forms can be used at home.

Q: Does insurance cover Spravato or generic ketamine?

Spravato may be covered by some insurance plans, particularly for patients with a documented diagnosis of treatment-resistant depression who have failed adequate trials of other antidepressants. Prior authorization is typically required. Generic ketamine used off-label for depression is generally not covered by insurance, though HSA/FSA funds can usually be applied.

Q: Can I take Spravato at home?

No. Due to FDA requirements (REMS program), Spravato must be administered at a certified healthcare facility, and patients must be monitored for at least two hours after each dose. Generic oral or sublingual ketamine, when prescribed off-label, can be taken at home under physician guidance through programs like Isha Health.

Spravato (esketamine) and generic ketamine are closely related but not identical. Spravato is an FDA-approved intranasal spray manufactured by Janssen for treatment-resistant depression (TRD). Generic ketamine, also called racemic ketamine, is a widely available medication that has been used off-label for depression in various forms, including oral, sublingual, IV, and intramuscular routes. Understanding the differences between these two options can help you have a better-informed conversation with your provider.

Comparison at a glance

Factor	Spravato (Esketamine)	Generic Ketamine (Racemic)
How it works	S-enantiomer of ketamine; NMDA receptor antagonism with higher binding affinity	Contains both S- and R-enantiomers; NMDA antagonism plus potential additional effects from R-ketamine
Speed of relief	Clinical trials showed improvement within days to weeks	Some patients report improvement within hours to days, depending on route
Administration	Intranasal spray at a certified healthcare facility; 2-hour post-dose monitoring required (REMS)	Oral, sublingual, IV, or IM; oral/sublingual can be used at home with telemedicine support
Cost	$600-900+ per session without insurance; may be partially covered by some plans with prior authorization	At-home oral: ~$350/appointment + $50-150/mo medication; IV infusions: $400-800/session
FDA status	FDA-approved specifically for treatment-resistant depression (2019) and major depressive disorder with suicidal ideation (2020)	FDA-approved as an anesthetic only; prescribed off-label for depression by licensed physicians
Side effects	Dissociation, dizziness, nausea, sedation, elevated blood pressure, nasal discomfort	Dissociation, nausea, dizziness, elevated blood pressure; profile varies by route of administration
Evidence level	Phase III clinical trials supporting FDA approval; post-marketing data accumulating	Extensive research including meta-analyses; large real-world retrospective studies for oral route

Key differences

FDA approval vs. off-label use: Spravato is the only ketamine-related product FDA-approved specifically for depression (TRD and MDD with suicidal ideation). This approval means it has undergone rigorous Phase III clinical trials. Generic ketamine is prescribed off-label for depression, which is a common and legal practice but means it has not gone through the same regulatory approval process specifically for this indication. Both approaches are used by qualified physicians.

Setting and convenience: Spravato's FDA approval comes with a Risk Evaluation and Mitigation Strategy (REMS), requiring administration at a certified facility with 2-hour post-dose monitoring. This means visiting a clinic for every session. Generic oral ketamine can be prescribed for at-home use under physician guidance through telehealth programs like Isha Health, offering significantly more convenience and flexibility.

Molecular differences: Spravato contains only esketamine (the S-enantiomer), while generic ketamine contains both the S- and R-enantiomers. Some researchers have proposed that the R-enantiomer may have its own antidepressant properties, potentially through mechanisms beyond NMDA receptor antagonism. This is still an active area of research, and it remains unclear whether racemic ketamine offers advantages over esketamine alone, or vice versa.

Insurance and cost: Spravato may be covered by insurance for patients who meet specific criteria, though prior authorization can be a lengthy process. Without insurance, Spravato sessions can cost $600-900 or more. Generic oral ketamine is generally not covered by insurance but is typically less expensive out-of-pocket, especially through at-home programs. HSA and FSA funds can be used for both.

When to consider generic ketamine

You prefer the convenience of at-home treatment without clinic visits for every session
You want a more affordable out-of-pocket option
You are interested in oral or sublingual administration with telemedicine support
You do not have insurance coverage for Spravato or cannot navigate the prior authorization process

When to consider Spravato

You prefer an FDA-approved product specifically indicated for your diagnosis
Your insurance covers Spravato and the prior authorization process is manageable
You prefer in-clinic administration with on-site monitoring for every session
Your provider specifically recommends Spravato based on your clinical profile

Frequently asked questions

What is the difference between Spravato and ketamine?

Spravato contains esketamine (the S-enantiomer of ketamine) and is FDA-approved for TRD. Generic ketamine contains both S- and R-enantiomers and is prescribed off-label. Spravato is intranasal and clinic-only; generic ketamine comes in multiple forms including oral for at-home use.

Is Spravato more effective than generic ketamine?

There is no definitive evidence that Spravato is more effective than generic racemic ketamine. Some researchers suggest racemic ketamine may have advantages due to the R-enantiomer. Head-to-head comparisons are limited. Both have shown clinical benefit.

Does insurance cover Spravato or generic ketamine?

Spravato may be covered by some insurance plans with prior authorization. Generic ketamine for depression is generally not covered, though HSA/FSA can be used. See our pricing page for Isha Health rates.

Can I take Spravato at home?

No. Due to the FDA REMS program, Spravato must be administered at a certified facility with 2-hour monitoring. Generic oral ketamine can be taken at home under physician guidance through programs like Isha Health.

Want to learn more about generic ketamine therapy?

Our physicians can explain your options and help you decide what is right for you.

Check Appointment Availability